Nutraferon CT-PRIDE Tablets

Antacids neutralize stomach acid and PPIs reduce acid secretion, whereas Nutraferon CT-PRIDE is a prokinetic agent that corrects the mechanical problem of slow stomach emptying and weak lower esophageal sphincter tone. It is often prescribed alone for dysmotility dyspepsia or alongside a PPI for GERD.

Taking the tablet 15 minutes before eating allows Cinitapride to reach the enteric nerve receptors and initiate coordinated gastric muscle contractions just as food enters the stomach.

While Cinitapride enhances overall gastrointestinal transit and can help patients whose functional dyspepsia is accompanied by sluggish bowel habits, it acts predominantly on the upper GI tract (esophagus, stomach, and duodenum) and is contraindicated if mechanical bowel obstruction, GI hemorrhage, or perforation is suspected.

Yes. Anticholinergic medications (such as atropine, hyoscine, or dicyclomine) directly oppose Cinitapride's prokinetic action. Additionally, potent CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, or ritonavir) and alcohol or CNS sedatives should be avoided.

Nutraferon CT-PRIDE 1 mg is generally well tolerated. Occasional mild drowsiness, diarrhea, abdominal borborygmi (rumbling), or very rare extrapyramidal symptoms (muscle stiffness or restlessness, mainly in elderly patients or high doses) should be reported to your doctor.